Gold seed fiducial markers for prostate radiation therapy: Describing prostate motiondoi:10.1002/j.2051-3909.2011.tb00152.xgold seed fiducial markerprostate localisationimagingPurpose : Gold seed fiducial markers can be used to accurately define daily treatment field placement for prostate cancer patients....
Both stem cells and cancer cells are thought to be capable of unlimited proliferation. Moreover, a small number of cancer cells express stem cell markers, ... T Kondo - 《Cancer Biomarkers》 被引量: 146发表: 2007年 Cancer Stem Cells: Targets and Potential Biomarkers for Radiotherapy Koch, ...
Functional Imaging for Radiation Treatment Planning, Response Assessment, and Adaptive Therapy in Head and Neck Cancer Patients with squamous cell carcinomas (SCCs) of the head and neck are increasingly treated nonsurgically. Imaging plays a critical role in helping define ... P Bhatnagar,M Subesin...
Radiation therapy plays a critical role in the management of a majority of patients diagnosed with cancer. Identification of factors that help predict which patients are at risk for relapse within the irradiated field remains an active area of investigat
Fiducial Markers Implanted during Prostate Brachytherapy for Guiding Conformal External Beam Radiation Therapy Prostate movement imposes limits on safe dose-escalation with external beam radiation therapy. If the precise daily location of the prostate is known, dose... JS Welsh,C Berta,S Borzillary,....
Prostate Cancer Prostatic Dis.2014;17:64-69 Crossref Scopus (113) PubMed Google Scholar 57. Brett, S.I. ∙ Kim, Y. ∙ Biggs, C.N. ... Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer ...
The significance of perineural invasion in prostate cancer biopsies remains questionable. In a systematic review Harnden et al. addressed important limitations of 21 studies on perineural invasion in biopsies followed by radical prostatectomy or radiation therapy [47]. First, the presence of nerves in ...
We predicted the sensitivity (log IC50 concentration) of a panel of 930 cell lines (separately for 29 cancer types that had a sufficient number of cell lines available) to a set of 518 drugs from the GDSC database37. In particular, we used Random Forest (RF) regression applied to the co...
Individuals subjected to methods of the invention may have received or are receiving a melanoma therapy, such as one that comprises surgery, radiation, chemotherapy, or immunotherapy, for example. Individuals subjected to the methods of the invention may be a mammal, such as human. Samples obtained...
The invention also concerns biallelic markers of the PCTA-1 gene and the association established between these markers and prostate cancer. The invention provides means to determine the predisposition of individuals to prostate cancer as well as means for the diagNo.sis of prostate cancer and for ...